Trial Profile
A retrospective study assessing Glomerular filtration rate in patients concomitantly treated with ledipasvir and tenofovir
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 30 Aug 2017 New trial record
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science